232 related articles for article (PubMed ID: 1678713)
1. Relationship between regulation of morphine-induced EEG effects and changes in naloxone sensitivity.
Paquette NC; Young GA
Eur J Pharmacol; 1991 Apr; 196(1):61-7. PubMed ID: 1678713
[TBL] [Abstract][Full Text] [Related]
2. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
Hong O; Young GA; Khazan N
Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
[TBL] [Abstract][Full Text] [Related]
3. Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra.
Stamidis H; Young GA
Eur J Pharmacol; 1992 Mar; 213(1):9-16. PubMed ID: 1499659
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin octapeptide alters morphine-induced effects on EEG power spectra both quantitatively and qualitatively.
Hudson GM; Marquis KL; Stamidis H; Young GA
Eur J Pharmacol; 1992 Oct; 221(2-3):217-22. PubMed ID: 1426001
[TBL] [Abstract][Full Text] [Related]
5. Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole.
Stamidis H; Young GA
Peptides; 1993; 14(3):511-7. PubMed ID: 8392719
[TBL] [Abstract][Full Text] [Related]
6. Dynorphin A-(1-13)-morphine interactions: quantitative and qualitative EEG properties differ in morphine-naive vs. morphine-tolerant rats.
Meng Y; Young GA
Brain Res Bull; 1994; 33(3):255-65. PubMed ID: 7904888
[TBL] [Abstract][Full Text] [Related]
7. Mu-delta opioid interactions. II: Beta-FNA inhibits DPDPE-induced increases in morphine EEG and EEG spectral power.
Stamidis H; Young GA
Peptides; 1992; 13(4):755-60. PubMed ID: 1331999
[TBL] [Abstract][Full Text] [Related]
8. Differential neuropharmacological effects of mu, kappa and sigma opioid agonists on cortical EEG power spectra in the rat. Stereospecificity and naloxone antagonism.
Young GA; Khazan N
Neuropharmacology; 1984 Oct; 23(10):1161-5. PubMed ID: 6097833
[TBL] [Abstract][Full Text] [Related]
9. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa opioid agonists in the rat.
Young GA; Khazan N
Neuropharmacology; 1984 May; 23(5):505-9. PubMed ID: 6330605
[TBL] [Abstract][Full Text] [Related]
10. Pressor, tachycardic and feeding responses in conscious rats following i.c.v. administration of dynorphin. Central blockade by opiate and alpha 1-receptor antagonists.
Saunders WS; Thornhill JA
Regul Pept; 1987 Nov; 19(3-4):209-20. PubMed ID: 2893437
[TBL] [Abstract][Full Text] [Related]
11. Mu-delta opioid interactions. I: The delta peptide, DPDPE, increases morphine-induced EEG and EEG spectral power.
Stamidis H; Young GA
Peptides; 1992; 13(4):749-53. PubMed ID: 1331998
[TBL] [Abstract][Full Text] [Related]
12. Intracerebroventricular physostigmine-induced analgesia: enhancement by naloxone, beta-funaltrexamine and nor-binaltorphimine and antagonism by dynorphin A (1-17).
Fujimoto JM; Rady JJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):1045-52. PubMed ID: 2574738
[TBL] [Abstract][Full Text] [Related]
13. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
Russell JA; Coombes JE; Leng G; Bicknell RJ
J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
[TBL] [Abstract][Full Text] [Related]
14. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; Kehr J; Ungerstedt U; Terenius L
Brain Res; 1996 Feb; 710(1-2):241-8. PubMed ID: 8963665
[TBL] [Abstract][Full Text] [Related]
15. Self-administration of dynorphin-[1-13] and D-ala2-dynorphin-[1-11] (kappa opioid agonists) in morphine (mu opioid agonist)-dependent rats.
Khazan N; Young GA; Calligaro D
Life Sci; 1983; 33 Suppl 1():559-62. PubMed ID: 6319910
[TBL] [Abstract][Full Text] [Related]
16. Naloxone and norbinaltorphimine administered intracerebroventricularly antagonize spinal morphine-induced antinociception in mice through the antianalgesic action of spinal dynorphin A (1-17).
Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1992 Apr; 261(1):146-53. PubMed ID: 1348537
[TBL] [Abstract][Full Text] [Related]
17. Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and kappa-opioid receptor implicated.
Wu LZ; Cui CL; Tian JB; Ji D; Han JS
Brain Res; 1999 Dec; 851(1-2):290-6. PubMed ID: 10642860
[TBL] [Abstract][Full Text] [Related]
18. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
Fox DA; Burks TF
J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
[TBL] [Abstract][Full Text] [Related]
19. Spinal kappa receptor-mediated analgesia of E-2078, a systemically active dynorphin analog, in mice.
Nakazawa T; Furuya Y; Kaneko T; Yamatsu K
J Pharmacol Exp Ther; 1991 Jan; 256(1):76-81. PubMed ID: 1671100
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
